ARQT vs MSFT: Which Stock is Better?
Side-by-side comparison of Arcutis Biotherapeutics Inc and Microsoft Corporation in 2026
ARQT
Arcutis Biotherapeutics Inc
$23.85
MSFT
Microsoft Corporation
$498.41
Key Metrics Comparison
| Metric | ARQT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.64B | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | MSFT |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze ARQT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARQT or MSFT a better investment?
Comparing ARQT and MSFT: Arcutis Biotherapeutics Inc has a market cap of $1.64B while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARQT and MSFT?
ARQT (Arcutis Biotherapeutics Inc) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARQT or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARQT or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for ARQT.
Which company is more profitable: ARQT or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for ARQT.
Which is the larger company: ARQT or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $1.64B for ARQT.
Should I buy ARQT or MSFT in 2026?
Both ARQT and MSFT have investment merit. ARQT trades at $23.85 while MSFT trades at $498.41. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARQT and MSFT stock?
Key differences: Market Cap ($1.64B vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy ARQT or MSFT in 2026?
The choice between ARQT and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ARQT and MSFT?
ARQT (Arcutis Biotherapeutics Inc) has a market cap of $1.64B, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.